Q4 2020 Arcturus Therapeutics Holdings Inc Earnings Call Transcript
Greetings, and welcome to the Arcturus Therapeutics Fourth Quarter and Full Year 2020 Earnings Call. (Operator Instructions)
As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Neda Safarzadeh, Head of Investor Relations, Public Relations and Marketing. Thank you, Neda. You may begin.
/&
Thank you, operator, and good afternoon, everyone. We are joined today by Joseph Payne, President and CEO; Andy Sassine, CFO; Dr. Pad Chivukula, CSO and COO; Dr. Steve Hughes, our Chief Medical Officer; and Professor Eng Ooi, Deputy Director of Emerging Infectious Diseases program from Duke-NUS Medical School, who is also in Arcturus' Vaccine Platform Scientific Advisory Board.
Before we begin, I would like to remind everyone that except for statements of historical facts, the statements made by management and any responses to questions on this conference call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |